After targeting Tylenol for pregnant women (which was debunked by medical experts), Health and Human Services Secretary RFK Jr. is targeting abortion pills by using the power of the Federal Drug Administration (FDA), reports ABC News:
Republicans and anti-abortion advocates have been pressing the Trump administration to change the FDA’s rules around mifepristone, an oral drug typically used in combination with another drug, misoprostol, to induce an abortion or to help manage an early miscarriage.
If access to the pill were restricted, either by banning telehealth access or narrowing the window when women can use it, it would significantly cut back on abortion access in post-Roe v. Wade America, where at least 16 states have ceased nearly all abortion services.
Kennedy and FDA Commissioner Marty Makary, in their letter to 22 Republican attorneys general who had requested the FDA review mifepristone’s safety, said the FDA would conduct “its own review of the evidence, including real-world outcomes and evidence, relating to the safety and efficacy of the drug.”
…Kiki Freedman, co-founder and CEO of Hey Jane, the largest telemedicine abortion provider in the country, told ABC News on Wednesday that the new HHS review could “undermine access to one of the most thoroughly studied and widely used medications in the country.”
“HHS Secretary RFK Jr and FDA Commissioner Marty Makary’s threat to conduct their own ‘review’ of mifepristone underscores the disturbing rise of junk science and politically motivated attacks in shaping public health policy,” Freedman said.
(Source: ABC News)